PCSK9 and coronary artery disorder: Higher circulating plasma levels of PCSK9 has been shown to positively correlate with plasma levels of LDL and susceptibility to CAD; individuals with a PCSK9 loss of function display reduced LDL levels and lower risk of CAD [78].